Novel Agents in the Management of Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4291-4325
Author(s):
B. Kennedy, F. Gargoum, B. Bystricky, D. R. Curran and T. M. O'Connor
PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4326-4341
Author(s):
P. Wu and Y.-Z. Hu
Gain of Function Effects of Z Alpha-1 Antitrypsin
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
9
Page:
336-346
Author(s):
Tomas P. Carroll, Noel G. McElvaney and Catherine M. Greene
PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4433-4447
Author(s):
M. Mazzoletti and M. Broggini
Microsatellite Instability (MSI) as Genomic Marker in Endometrial Cancer: Toward Scientific Evidences
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
10
Page:
1356-1365
Author(s):
A. Tinelli, V. Mezzolla, G. Leo, M. Pisano, F. Storelli, G. Alemanno, A. Malvasi, S. Tommasi, G. Ronzino and V. Lorusso
Bladder Cancer Stem Cells
Journal:
Current Stem Cell Research & Therapy
Volume:
5
Page:
387-395
Author(s):
Mai N. Tran, Goodwin Jinesh G., David J. McConkey and Ashish M. Kamat
Cysteine Protease Inhibitors: from Evolutionary Relationships to Modern Chemotherapeutic Design for the Treatment of Infectious Diseases
Journal:
Current Protein & Peptide Science
Volume:
11
Page:
725-743
Author(s):
E. C.Y. Toh, N. L. Huq, S. G. Dashper and E. C. Reynolds
Erbin, a Negative Regulator in Diverse Signal Pathways
Journal:
Current Protein & Peptide Science
Volume:
11
Page:
759-764
Author(s):
Dan Liu, Ming Shi, Huijun Duan, Caili Han and Ning Guo
Current Concepts and Future Directions in Radioimmunotherapy
Journal:
Current Drug Discovery Technologies
Volume:
7
Page:
253-262
Author(s):
Frank I. Lin and Andrei Iagaru
Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Journal:
Current Drug Discovery Technologies
Volume:
7
Page:
263-279
Author(s):
Bart Cornelissen and Katherine A Vallis